IRIDEX Current Ratio 2010-2024 | IRIX
IRIDEX current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| IRIDEX Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-09-30 |
$0.02B |
$0.02B |
1.54 |
| 2024-06-30 |
$0.03B |
$0.02B |
1.55 |
| 2024-03-31 |
$0.03B |
$0.02B |
1.72 |
| 2023-12-31 |
$0.03B |
$0.01B |
2.12 |
| 2023-09-30 |
$0.03B |
$0.01B |
2.64 |
| 2023-06-30 |
$0.03B |
$0.01B |
2.53 |
| 2023-03-31 |
$0.04B |
$0.01B |
2.64 |
| 2022-12-31 |
$0.04B |
$0.01B |
2.87 |
| 2022-09-30 |
$0.04B |
$0.01B |
2.81 |
| 2022-06-30 |
$0.04B |
$0.01B |
3.19 |
| 2022-03-31 |
$0.04B |
$0.01B |
3.33 |
| 2021-12-31 |
$0.04B |
$0.01B |
3.34 |
| 2021-09-30 |
$0.04B |
$0.01B |
3.39 |
| 2021-06-30 |
$0.04B |
$0.01B |
4.00 |
| 2021-03-31 |
$0.04B |
$0.01B |
3.47 |
| 2020-12-31 |
$0.03B |
$0.01B |
2.92 |
| 2020-09-30 |
$0.03B |
$0.01B |
2.77 |
| 2020-06-30 |
$0.03B |
$0.01B |
3.40 |
| 2020-03-31 |
$0.03B |
$0.01B |
3.44 |
| 2019-12-31 |
$0.03B |
$0.01B |
3.12 |
| 2019-09-30 |
$0.03B |
$0.01B |
3.36 |
| 2019-06-30 |
$0.03B |
$0.01B |
3.41 |
| 2019-03-31 |
$0.04B |
$0.01B |
3.63 |
| 2018-12-31 |
$0.04B |
$0.01B |
3.77 |
| 2018-09-30 |
$0.04B |
$0.01B |
3.98 |
| 2018-06-30 |
$0.03B |
$0.01B |
3.28 |
| 2018-03-31 |
$0.04B |
$0.01B |
3.77 |
| 2017-12-31 |
$0.04B |
$0.01B |
3.80 |
| 2017-09-30 |
$0.04B |
$0.01B |
5.38 |
| 2017-06-30 |
$0.04B |
$0.01B |
5.61 |
| 2017-03-31 |
$0.05B |
$0.01B |
6.28 |
| 2016-12-31 |
$0.05B |
$0.01B |
5.62 |
| 2016-09-30 |
$0.03B |
$0.01B |
4.16 |
| 2016-06-30 |
$0.03B |
$0.01B |
3.77 |
| 2016-03-31 |
$0.03B |
$0.01B |
4.16 |
| 2015-12-31 |
$0.03B |
$0.01B |
4.14 |
| 2015-09-30 |
$0.03B |
$0.01B |
4.40 |
| 2015-06-30 |
$0.03B |
$0.01B |
4.53 |
| 2015-03-31 |
$0.03B |
$0.01B |
4.60 |
| 2014-12-31 |
$0.03B |
$0.01B |
4.67 |
| 2014-09-30 |
$0.03B |
$0.01B |
4.73 |
| 2014-06-30 |
$0.03B |
$0.01B |
4.91 |
| 2014-03-31 |
$0.03B |
$0.01B |
5.15 |
| 2013-12-31 |
$0.03B |
$0.01B |
4.34 |
| 2013-09-30 |
$0.03B |
$0.01B |
4.66 |
| 2013-06-30 |
$0.03B |
$0.01B |
4.44 |
| 2013-03-31 |
$0.03B |
$0.01B |
5.00 |
| 2012-12-31 |
$0.03B |
$0.01B |
4.25 |
| 2012-09-30 |
$0.03B |
$0.01B |
4.79 |
| 2012-06-30 |
$0.03B |
$0.01B |
4.94 |
| 2012-03-31 |
$0.03B |
$0.01B |
4.82 |
| 2011-12-31 |
$0.03B |
$0.01B |
3.31 |
| 2011-09-30 |
$0.03B |
$0.01B |
3.29 |
| 2011-06-30 |
$0.03B |
$0.01B |
3.36 |
| 2011-03-31 |
$0.03B |
$0.01B |
3.01 |
| 2010-12-31 |
$0.03B |
$0.01B |
2.87 |
| 2010-09-30 |
$0.03B |
$0.01B |
2.75 |
| 2010-06-30 |
$0.02B |
$0.01B |
2.72 |
| 2010-03-31 |
$0.02B |
$0.01B |
2.46 |
| 2009-12-31 |
$0.03B |
$0.01B |
2.01 |
| 2009-09-30 |
$0.03B |
$0.01B |
1.94 |
| 2009-06-30 |
$0.03B |
$0.01B |
1.85 |
| 2009-03-31 |
$0.03B |
$0.02B |
1.63 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.028B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
